Clinical trials
Phase 2 Periodontal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Forsyth Institute | 3 |
| October 6 University | 2 |
| Fayoum University | 1 |
| King Edward Memorial Hospital | 1 |
| Mahsa University | 1 |
| National Cancer Institute (NCI) | 1 |
| Noveome Biotherapeutics, formerly Stemnion | 1 |
| Universidad Autonoma de Nuevo Leon | 1 |
| Universidad El Bosque, Bogotá | 1 |
| Universidad de los Andes, Chile | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Periodontal Diseases | 20 |
| Periodontitis | 5 |
| Chronic Periodontitis | 4 |
| Dental Plaque | 2 |
| Bacteremia | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Gingivitis | 1 |
| Leukoplakia | 1 |
| Pre-Eclampsia | 1 |
| Premature Birth | 1 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.